Engineered iPSC-Derived NK Cells Expressing Recombinant CD64 for Enhanced ADCCKate Dixon, Bruce Walcheck, Melissa Khaw et al.|Blood|2020Cited by 8
Arming of iPSC-Derived NK Cells Expressing a Novel CD64 Fusion Receptor with Therapeutic Antibodies Represents a Novel Off-the-Shelf, Antigen-Targeting Strategy for CancerKate Dixon, Bruce Walcheck, Kristin M. Snyder et al.|Blood|2021Cited by 0